To explore how MDH2 expression modifies the metabolic profiles of breast cancer cells, we extracted polar metabolites from vector control and MDH2-OE MDA-MB-231 cell samples and performed untargeted LC-MS metabolomics analysis, as outlined in the flowchart (Fig. 7a). This evidence concerns the gene MDH2 and breast carcinoma.